AbCellera Biologics, Inc. (ABCL)
11.94
-0.52
(-4.17%)
USD |
NASDAQ |
Nov 11, 16:00
11.98
+0.04
(+0.34%)
After-Hours: 17:34
AbCellera Biologics Debt to Equity Ratio : 0.126 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.126 |
| June 30, 2026 | 0.1514 |
| March 31, 2026 | 0.1494 |
| December 31, 2025 | 0.1481 |
| September 30, 2025 | 0.1475 |
| June 30, 2025 | 0.1411 |
| March 31, 2025 | 0.0663 |
| December 31, 2024 | 0.0619 |
| September 30, 2024 | 0.0662 |
| June 30, 2024 | 0.0649 |
| March 31, 2024 | 0.0651 |
| December 31, 2023 | 0.0672 |
| September 30, 2023 | 0.0683 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.0703 |
| March 31, 2023 | 0.0688 |
| December 31, 2022 | 0.0667 |
| September 30, 2022 | 0.0609 |
| June 30, 2022 | 0.0303 |
| March 31, 2022 | 0.0334 |
| December 31, 2021 | 0.0391 |
| September 30, 2021 | 0.0315 |
| June 30, 2021 | 0.0344 |
| March 31, 2021 | 0.0193 |
| December 31, 2020 | 0.0082 |
| September 30, 2020 | 0.0663 |
| June 30, 2020 | 0.2171 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| MindWalk Holdings Corp. | 0.5041 |
| Agilent Technologies, Inc. | 0.5363 |
| Bio-Rad Laboratories, Inc. | 0.1793 |
| Bruker Corp. | 0.7497 |
| Azenta, Inc. | 0.0357 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.500B |
| Total Liabilities (Quarterly) | 257.09M |
| Shareholders Equity (Quarterly) | 1.062B |
| Current Ratio | 12.43 |
| Net Debt Paydown Yield | 0.03% |